Chemoinformaics analysis of HEXOURONIC ACID
| Molecular Weight | 194.139 | nRot | 5 |
| Heavy Atom Molecular Weight | 184.059 | nRig | 2 |
| Exact Molecular Weight | 194.043 | nRing | 0 |
| Solubility: LogS | -0.15 | nHRing | 0 |
| Solubility: LogP | -2.174 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 22.3019 |
| nHD | 5 | BPOL | 11.7681 |
| QED | 0.223 |
| Synth | 3.863 |
| Natural Product Likeliness | 0.849 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.069 |
| HIA | 0.849 |
| CACO-2 | -5.669 |
| MDCK | 0.00513205 |
| BBB | 0.799 |
| PPB | 0.158045 |
| VDSS | 0.264 |
| FU | 0.679844 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.029 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.059 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.015 |
| CL | 1.334 |
| T12 | 0.787 |
| hERG | 0.033 |
| Ames | 0.028 |
| ROA | 0.006 |
| SkinSen | 0.102 |
| Carcinogencity | 0.002 |
| EI | 0.157 |
| Respiratory | 0.317 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.881965 |